Abnormal Metabolic Brain Networks in a Nonhuman Primate Model of Parkinsonism

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Journal of Cerebral Blood Flow and Metabolism

• Publication date

  2012-04-01

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1038/jcbfm.2011.166PMID 22126913PMCID PMC3318142
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Modulation of Abnormal Metabolic Brain Networks by Experimental Therapies in a Nonhuman Primate Model of Parkinson Disease: An Application to Human Retinal Pigment Epithelial Cell Implantation

  2016cited by this paper
• Scaled subprofile modeling of resting state imaging data in Parkinson's disease: Methodological issues

  2011cited by this paper
• Network correlates of the cognitive response to levodopa in Parkinson disease

  2011cited by this paper
• Parkinson's Disease Spatial Covariance Pattern: Noninvasive Quantification with Perfusion MRI

  2010cited by this paper
• Multivariate Data Analysis for Neuroimaging Data: Overview and Application to Alzheimer’s Disease

  2010influential reference
• Abnormalities in Metabolic Network Activity Precede the Onset of Motor Symptoms in Parkinson's Disease

  2010cited by this paper
• Metabolic brain networks in neurodegenerative disorders: a functional imaging approach.

  2009cited by this paper
• Dissociation of Metabolic and Neurovascular Responses to Levodopa in the Treatment of Parkinson's Disease

  2008cited by this paper
• Functional Imaging of Cerebral Blood Flow and Glucose Metabolism in Parkinson’s Disease and Huntington’s Disease

  2007cited by this paper
• Changes in network activity with the progression of Parkinson's disease.

  2007cited by this paper
• Performance evaluation of the ECAT HRRT: an LSO-LYSO double layer high resolution, high sensitivity scanner

  2007influential reference
• Subthalamic Glutamic Acid Decarboxylase Gene Therapy: Changes in Motor Function and Cortical Metabolism

  2007cited by this paper
• Abnormal Metabolic Network Activity in Parkinson'S Disease: Test—Retest Reproducibility

  2007cited by this paper
• Reciprocal Benefits of Mass-Univariate and Multivariate Modeling in Brain Mapping: Applications to Event-Related Functional MRI, H2 15O-, and FDG-PET

  2006cited by this paper
• Imaging Visual Recognition Memory Network by PET in the Baboon: Perirhinal Cortex Heterogeneity and Plasticity after Perirhinal Lesion

  2006cited by this paper
• Network modulation in the treatment of Parkinson's disease.

  2006cited by this paper
• Involvement of Sensorimotor, Limbic, and Associative Basal Ganglia Domains in L-3,4-Dihydroxyphenylalanine-Induced Dyskinesia

  2005cited by this paper
• A New Approach to Spatial Covariance Modeling of Functional Brain Imaging Data: Ordinal Trend Analysis

  2005cited by this paper
• PET imaging of implanted human retinal pigment epithelial cells in the MPTP-induced primate model of Parkinson's disease.

  2004cited by this paper
• Mapping of brain function after MPTP-induced neurotoxicity in a primate Parkinson's disease model

  2003influential reference
• Template Images for Nonhuman Primate Neuroimaging: 2. Macaque

  2001influential reference
• Metabolic correlates of levodopa response in Parkinson’s disease

  2001cited by this paper
• Pattern of dopaminergic loss in the striatum of humans with MPTP induced parkinsonism

  2000cited by this paper
• Mapping the Visual Recognition Memory Network with PET in the Behaving Baboon

  2000cited by this paper
• Primate brain maps : structure of the macaque brain

  2000cited by this paper
• Reproducibility of regional metabolic covariance patterns: comparison of four populations.

  1999cited by this paper
• Regional metabolic changes in the pedunculopontine nucleus of unilateral 6-hydroxydopamine Parkinson's model rats.

  1999cited by this paper
• 6‐[18F]fluoro‐L‐DOPA PET studies of the turnover of dopamine in MPTP‐induced parkinsonism in monkeys

  1998cited by this paper
• Oral 18F-fluoro-2-deoxyglucose for primate PET studies without behavioral restraint: demonstration of principle.

  1997cited by this paper
• Oral 18F‐fluoro‐2‐deoxyglucose for primate PET studies without behavioral restraint: Demonstration of principle

  1997cited by this paper
• Neural mechanisms underlying parkinsonian symptoms based upon regional uptake of 2-deoxyglucose in monkeys exposed to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.

  1989cited by this paper

• Neuroprotective potential of isofraxidin: Alleviating parkinsonian symptoms, inflammation and microglial activation

  2025cites this paper
• Positron Emission Tomography Imaging in Clinical Trials for Parkinson's Disease: Applications of Metabolic Brain Network Approach

  2025cites this paper
• A framework for translational therapy development in deep brain stimulation

  2024cites this paper
• PET imaging in animal models of Parkinson's disease.

  2022cites this paper
• A bibliometric analysis of neuroimaging biomarkers in Parkinson disease based on Web of Science

  2022cites this paper
• Dynamic 18F-FPCIT PET: Quantification of Parkinson Disease Metabolic Networks and Nigrostriatal Dopaminergic Dysfunction in a Single Imaging Session

  2021cites this paper
• Use of positron-emission tomography as a diagnostic and differential diagnostic tool in parkinsonian syndromes

  2020cites this paper
• The Ventral Intermediate Nucleus Differently Modulates Subtype-Related Networks in Parkinson’s Disease

  2019cites this paper
• Network Imaging in Parkinsonian and Other Movement Disorders: Network Dysfunction and Clinical Correlates.

  2019cites this paper
• The use of nonhuman primate models to understand processes in Parkinson’s disease

  2018cites this paper
• Pathophysiology of levodopa‐induced dyskinesia: Insights from multimodal imaging and immunohistochemistry in non‐human primates

  2018cites this paper
• The effects of image reconstruction algorithms on topographic characteristics, diagnostic performance and clinical correlation of metabolic brain networks in Parkinson's disease.

  2018cites this paper
• Molecular imaging to track Parkinson's disease and atypical parkinsonisms: New imaging frontiers

  2017cites this paper
• Update on Molecular Imaging in Parkinson’s Disease

  2017cites this paper
• Levodopa-induced abnormal involuntary movements correlate with altered permeability of the blood-brain-barrier in the basal ganglia

  2017cites this paper
• Abnormal metabolic brain network associated with Parkinson’s disease: replication on a new European sample

  2017cites this paper
• Network Structure and Function in Parkinson’s Disease

  2017influential citation
• Modulation of Abnormal Metabolic Brain Networks by Experimental Therapies in a Nonhuman Primate Model of Parkinson Disease: An Application to Human Retinal Pigment Epithelial Cell Implantation

  2016cites this paper
• Reverse Translation in Parkinson Disease

  2016cites this paper
• How Relevant Are Imaging Findings in Animal Models of Movement Disorders to Human Disease?

  2015cites this paper
• Neuroimaging of Parkinson's disease: Expanding views.

  2015cites this paper
• Reproducibility of a Parkinsonism‐related metabolic brain network in non‐human primates: A descriptive pilot study with FDG PET

  2015cites this paper
• Effects of levodopa on regional cerebral metabolism and blood flow

  2015cites this paper
• Functional Imaging to Study Movement Disorders

  2015cites this paper
• Brain network markers of abnormal cerebral glucose metabolism and blood flow in Parkinson’s disease

  2014cites this paper
• Characterization of disease‐related covariance topographies with SSMPCA toolbox: Effects of spatial normalization and PET scanners

  2014cites this paper
• Dopamine: PET Imaging and Parkinson Disease.

  2013cites this paper
• Selection of Appropriate Reference Genes for RT-qPCR Analysis in a Streptozotocin-Induced Alzheimer’s Disease Model of Cynomolgus Monkeys (Macaca fascicularis)

  2013cites this paper
• Parkinson's Disease: Increased Motor Network Activity in the Absence of Movement

  2013cites this paper
• Functional neuroimaging in Parkinson's disease.

  2012cites this paper
• Functional brain networks and abnormal connectivity in the movement disorders

  2012cites this paper
• Functional brain networks in movement disorders: recent advances.

  2012cites this paper
• PEDF and VEGF-A Output from Human Retinal Pigment Epithelial Cells Grown on Novel Microcarriers

  2012cites this paper
• Metabolic brain networks in translational neurology: Concepts and applications

  2012cites this paper